FY 2016 Conference Call Note

Similar documents
Q Conference Call Note

Q Conference Call Note

FY 2017 Conference Call Note

Q Conference Call Note

Preliminary Release FY 2016e Additional Information

1 ST QUARTER 2013 CALL NOTE

WACKER CHEMIE AG 1 st Quarter 2009 CALL NOTE

Full Year 2013 Conference Call Note

WACKER CHEMIE AG 3 rd Quarter 2009 CALL NOTE

2 nd Quarter 2015 Conference Call Note

WACKER CHEMIE AG 1 st Quarter 2007 Call Note. Dr. Peter-Alexander Wacker (CEO), Dr. Joachim Rauhut (CFO)

Managing for Growth and Cash

Q Conference Call Presentation. Dr. Christoph von Plotho, CEO Rainer Irle, CFO October 29, 2015

Q Conference Call Presentation. Dr. Christoph von Plotho, CEO Rainer Irle, CFO July 31, 2015

ANNUAL PRESS CONFERENCE FOR 2015

Siltronic AG Preliminary Financial Figures FY February 1, 2018

Managing for Growth and Cash

Interim Report. January through March Published on April 26, 2018

ANNUAL PRESS CONFERENCE FOR 2016

Siltronic AG Q3/2017 Results. October 26, 2017

Siltronic AG Q3/2018 Results. October 25, 2018

ANNUAL PRESS CONFERENCE FOR 2017

Preliminary Financial Figures 2018

Interim Report January March 2016

Corporate Access: The Issuer s Perspective

GROUP SALES FOR Q REACH 1.31 BILLION, UP 14 PERCENT YEAR OVER YEAR AND 8 PERCENT QUARTER OVER QUARTER

WACKER ACHIEVES Q SALES ON PAR WITH A YEAR EARLIER AND SUBSTANTIALLY INCREASES EARNINGS

AFTER A GOOD FISCAL YEAR 2017, WACKER EXPECTS FURTHER SALES AND EARNINGS GROWTH FOR 2018

Siltronic a leading producer of silicon wafers. Roadshow Presentation March/April, 2017

PRESS RELEASE. WACKER Posts Higher Sales for 2018, with EBITDA Below Previous Year Due to As-Yet Outstanding Insurance Compensation.

Siltronic AG Roadshow Presentation. January, 2018

Siltronic a leading producer of silicon wafers. Roadshow Presentation April/May, 2017

Siltronic Roadshow Presentation. May / June 2018

Wacker Chemie AG Conference Call on the Full Year March 16 th, 2011

Siltronic Full Year Results March 5, 2018

Interim Report. January through September Published on October 26, 2017

Siltronic Investor Presentation. January 2019

Siltronic Investor Presentation. October/November 2018

Siltronic - Committed to sustainable growth. Dr. Christoph von Plotho CEO September 21, 2017

January March 2010 Conference Call. Georg Denoke Member of the Executive Board & CFO 4 May 2010

HELLA Investor Update H1 FY 2018/19

HELLA Investor Update H1 FY 2016/17

Q Results. Lars Brorsen (CEO) Christoph Hobo (CFO) November 22, 2018

HELLA Investor Update FY 2016/17

ELKEM FIRST QUARTER RESULTS May 2018

HELLA Investor Update FY 2017/18

HELLA Investor Update 9M FY 2017/18

Siltronic looks back on a very successful fiscal year 2017

HELLA Investor Update H1 FY 2017/18

Analyst & Investor Fact Sheet Q1 2018

QUARTERLY STATEMENT Q1/2017

Ludwigshafen, February 26, 2016

Siltronic successfully closes the financial year 2018 and plans to pay a dividend of EUR 5.00 per share

Nilfisk Q2 Interim Report 2018 Webcast presentation August 14

centrotherm photovoltaics AG Interim Report 1 January to 31 March May 2008

January June 2010 Conference Call. Georg Denoke Member of the Executive Board & CFO 2 August 2010

Wacker Neuson SE. Analyst conference results for Q May 14, Dr.-Ing. Georg Sick, CEO - Mag. Günther Binder, CFO.

FUCHS GROUP. Financial Results Analyst s Conference, 21 st March 2018, Frankfurt Stefan Fuchs, CEO Dagmar Steinert, CFO

Q3 9M 2017 RESULTS. Investor Presentation. 9 November 2017

Analyst & Investor Fact Sheet Q3 2017

Analyst & Investor Fact Sheet Q3 2018

OSRAM holding its ground in a difficult market environment

Results Q May 12, Dr.-Ing. Georg Sick (CEO and President) - Mag. Günther C. Binder (CFO) Reference (apr02)

Advancing Materials Innovation NASDAQ: GSM. Second Quarter

Sandvik. Record-high order intake in the quarter. Interim report on first quarter Sandvik first quarter 2012

INTERIM REPORT FOURTH QUARTER SANDVIK: Interim Report on the third quarter 2015

Q Supplemental Earnings Call Presentation. August 24, 2010

Martin Lindqvist, President & CEO Marco Wirén, CFO February 11, 2011

OSRAM with a solid start into FY18

H Interim Results. 18 May 2017

HELLA Investor Update Q1 2015/16

Full-Year / Fourth Quarter 2010 Results

KION UPDATE CALL Q Gordon Riske, CEO Thomas Toepfer, CFO Wiesbaden, 7 May 2015

Conference Call Q Results. Analysts Conference Call 30 April 2015

January March Conference Call. Georg Denoke Member of the Executive Board & CFO 4 May 2011

Analysts Conference Full Year Results 2004 Frankfurt, March 22, pm

Full year Vestas Wind Systems A/S. Copenhagen, 7 February Classification: Public

Q Financial Summary for Investors and Analysts

Revenue growth continued operative EBITDA improved from the prior year

Charts on Q2 2017/18 Facts & Figures

Linde Group. January - March 2006 Conference Call. April 26, Dr Peter Diesch, CFO

Investor and Analyst presentation Senvion S.A.

ELKEM THIRD QUARTER RESULTS October 2018

TELECONFERENCE PRESENTATION Q3 2012

Charts on Q1 2017/18 Facts & Figures

Global leader in high-end vacuum valve technology

SMA SOLAR TECHNOLOGY AG Analyst / Investor Presentation Financial Results 2017

KION GROUP AG Q Update Call. Gordon Riske (CEO), Anke Groth (CFO) Frankfurt, 26 July 2018

INEOS STYROLUTION. Q1/ 2017 Investor Earnings Call

January June Conference Call. Georg Denoke CFO and Member of the Executive Board 27 July 2012

ROADSHOW POST-Q2 & H RESULTS. September 2016

Quality assets. Selective and profitable growth. Self-funding business model

KRATON PERFORMANCE POLYMERS, INC. SECOND QUARTER 2013 EARNINGS CONFERENCE CALL. August 1, 2013

Linde Group. Full Year Results 2005

Siemens Gamesa Renewable Energy Q3 18 Results

Advancing Materials Innovation NASDAQ: GSM. Business Update. April

Q Conference Call May 14th, 2018

First Quarter 2018 Financial Results May 2, 2018

LANXESS FY/Q Financial Summary for Investors and Analysts

INEOS STYROLUTION. Q1/ 2018 Investor Earnings Call

Transcription:

CREATING TOMORROW`S SOLUTIONS Dr. Rudolf Staudigl (CEO), Dr. Tobias Ohler (CFO), March 14th, 2017 0 of 24

Disclaimer The information contained in this presentation is for background purposes only and is subject to amendment, revision and updating. Certain statements and information contained in this presentation may relate to future expectations and other forward-looking statements that are based on management's current views and assumptions and involve known and unknown risks and uncertainties. In addition to statements which are forward-looking by reason of context, including without limitation, statements referring to risk limitations, operational profitability, financial strength, performance targets, profitable growth opportunities, and risk adequate pricing, other words such as "may, will, should, expects, plans, intends, anticipates, believes, estimates, predicts, or continue", "potential, future, or further", and similar expressions identify forward-looking statements. By their nature, forward-looking statements involve a number of risks, uncertainties and assumptions which could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These include, among other factors, changing business or other market conditions and the prospects for growth anticipated by the Company's management. These and other factors could adversely affect the outcome and financial effects of the plans and events described herein. Statements contained in this presentation regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. The Company does not undertake any obligation to update or revise any statements contained in this presentation, whether as a result of new information, future events or otherwise. In particular, you should not place undue reliance on forward-looking statements, which speak only as of the date of this presentation. 1 of 24

Highlights Good Performance in Chemicals and Strong Cash Flow Strong Result Amid Challenging Environment: Key Targets Set for 2016 Achieved or Exceeded Sales of 5.4bn (+2% yoy) Financials Strong EBITDA excl. special income increase (+19% yoy) to 1,081m Net Cash Flow* at 401m, substantially up from 23m last year Chemical business with strong volumes, especially in SILICONES Operations Technical ramp of new polysilicon plant in Charleston, Tennessee completed Good cost and efficiency performance across all segments * Sum of cash flow from operating activities (excluding changes in advance payments) and cash flow from long-term investing activities (before securities), including additions due to finance leases. 2 of 24

2016 EBITDA Excl. Special Income Ahead of Guidance With High Utilization and Efficiency 2015 Guidance 2016 Sales ( m) 5,296 Slight increase 5,404 EBITDA ( m) EBITDA excl. special income ( m) 1,049 911 Expecting FY 5-10% higher excl. special income 1,101 1,081 EBITDA margin (%) 19.8 Somewhat lower 20.4 Net income ( m) 242 Below 2015 189 Net cash flow ( m) 23 Significantly positive 401 CapEx ( m) 834 About 425 428 Net financial debt ( m) 1,074 Slightly below prior-year level 993 Depreciation ( m) 575 About 720 735 ROCE (%) 8.1 Substantially lower 6.1 Tax Rate (%) 40.5 Close to 30% 28.5 3 of 24

Profit & Loss Statement: Increased Depreciation and Lower Special Income WACKER P&L 2016 ( m) m Sales 5,296.2 5,404.2 Gross profit from sales 1,129.1 990.7 Gross profit margin (in %) 21.3% 18.3% S,G&A and R&D Other operating income Other operating expenses -623.5 377.4-412.7-652.3 194.3-167.6 Operating result 470.3 365.1 EBIT 473.4 366.2 Interest result -24.5-36.4 Other financial result -42.2-65.0 Income before taxes 406.7 264.8 Income taxes -164.9-75.5 Net income for the period 241.8 189.3 EPS 4.97 3.61 Comments Sales +2.0% yoy: Volume/Mix +5.7%, Price -3.7%, FX +0.1% Gross profit decreased by 12.3% yoy on higher depreciation and moderate price pressure outpacing efficiency gains Other operating income / expense includes lower special income of 20m (2015: 138m) and lower net currency charge 17.5m (2015: 69.1m) Tax rate of 28.5% (2015: 40.5%) Depreciation at 735m (2015: 575m) EBITDA 1,048,8 1,101.4 Depreciation/amortization 575.4 735.2 EBIT 473.4 366.2 4 of 24

Net Financial Debt and Prepayments Decrease, Pension Liabilities About 0.5bn Lower Than at End of Q3/16 Balance Sheet (%) Characteristics 12/31/16 Non current assets: 5,279m Fixed assets Inventories Receivables Cash/ securities Assets 7.3bn 7.5bn 68.4% 64.0% 10.8% 11.3% 15.5% 18.5% 5.3% 6.2% Liabilities 7.3bn 38.5% 27.5% 20.0% 7.8% 6.2% 7.5bn 34.8% 34.3% 19.5% 7.8% 3.6% Equity Provisions Financial Liabilities Liabilities Advance payments received Securities, cash and cash equivalents: 466m Provisions for pensions: 2,108m (2015: 1,612m; Q3/16: 2,570m) Discount rate for defined benefit plans in Germany reduced to 1.94% (2015: 2.75%; Q3/16: 1.38%) DTA* relating to pensions about 340m Net financial debt decreases 82m yoy to 993m Equity: 2,593m 31/12/15 31/12/16 31/12/15 31/12/16 Prepayments: 271m (2015: 453m) * Deferred tax asset 5 of 24

SILICONES Strong Demand, High Plant Loading Sales ( m) +3% 1,943 2,001 EBITDA ( m) / margin +31% 276 361 14.2% 18.1% CapEx ( m) +8% 82 89 Highlights 2016 Strong demand for silicone products in all regions EBITDA benefitted from high plant loading, cost performance and product mix Outlook 2017 Mid-single-digit sales growth and slight increase in EBITDA despite rising raw material costs Expect good product mix and cost performance 6 of 24

POLYMERS Strong Demand and Efficiency Gains Support Margins Sales ( m) +1% 1,186 1,195 EBITDA ( m) / margin Highlights 2016 Sales slightly above prior year; strong volumes offset by lower pricing EBITDA yoy improved from high loading and good cost performance 222 18.7% 47 +17% 261 21.8% CapEx ( m) -21% 38 Outlook 2017 Mid-single-digit sales growth Expect FY EBITDA decrease from raw material inflation, but margin over target levels for Chemicals Growth in dispersions and powders with typical seasonality 7 of 24

BIOSOLUTIONS Positive Volume Effects Sales ( m) +5% 197 206 EBITDA ( m) / margin Highlights 2016 Sales +5% yoy Higher volumes in biopharmaceuticals and nutrition overcompensate lower prices in some product segments 32 16.3% 6 +15% CapEx ( m) +47% 37 17.9% 9 Outlook 2017 Low-single-digit sales growth EBITDA at about 30m due to integration costs from acquisition in Spain 8 of 24

POLYSILICON Strong Cash Generation Following Completion of Major CapEx Sales ( m) +3% 1,064 1,096 EBITDA ( m) / margin -29% 402 286 37.8% 26.1% CapEx ( m) -78% 582 130 Highlights 2016 Shipped 66kt (2015: 56kt), all plants fully loaded EBITDA below previous year due to lower special income ( 20m, 2015: 138m), ramp costs ( 48m) vs. pre-ops (2015: 90m) and lower yoy prices Op. EBITDA margin ex specials/ramp at 29% Outlook 2017 Sales at prior year level Volume growth, but lower ASP yoy EBITDA ex specials somewhat above 2016 Continued growth in shipments and focus on cost reduction 9 of 24

Siltronic Strong Volumes and Increasing Pricing Power Sales ( m) +0.2% 931 933 EBITDA ( m) / margin +18% 124 146 13.3% 15.2% 15.6% CapEx ( m) +19% 75 90 Highlights 2016 Sales at prior year level EBITDA benefitted yoy from high loading, good cost performance and lower FX hedging costs Outlook 2017 FY Sales expected over 1bn Significant increase in EBITDA with at least 20% margin, if not significantly higher 10 of 24

Net Financial Debt Strong Cash Flow Generation Net Financial Debt Bridge per Dec 31 st, 2016 ( m) -516.9 736.6-1,074.0-99.4-38.8-992.5 Net financial debt as of Dec. 31, 2015 Cash flow from operating activities (gross cash flow) * Cash flow from long-term investing activities before securities ** Dividend paid, Wacker Chemie AG Exchange-rate effects and other effects Net financial debt as of December 31, 2016 *) includes change in prepayments of 183m, **) includes financial investments 11 of 24

Q1 Trading Update Solid Volume Start, EBITDA Above Q1 2016 Trading Update Chemicals: Order intake and volumes over last year, raw materials prices up Polysilicon: Strong volumes and full utilization Siltronic: Strong demand for wafers, ASP up Q1 2017 Outlook Expect Q1 Group Sales at around 1.4bn EBITDA above Q1 2016 12 of 24

Guidance FY 2017 2016 Outlook 2017 Sales ( m) 5,404 Mid-single-digit % increase EBITDA excl. special income ( m) 1,081 At last year s level, on a comparable basis without special income EBITDA margin (%) 20.4 Slightly below last year s level Net cash flow ( m) 401 At last year s level CapEx ( m) 428 Around 450 Net financial debt ( m) 993 Substantially lower than last year Depreciation ( m) 735 Around 720 ROCE (%) 6.1 At last year s level Tax Rate (%) 28.5 Close to 30% 13 of 24

CREATING TOMORROW`S SOLUTIONS Conference Call: Q&A Session Dr. Rudolf Staudigl (CEO), Dr. Tobias Ohler (CFO), March 14th, 2017 14 of 24

Appendix 15 of 24

Full-Year Results 2016 Sales and EBITDA Breakdown Sales 1 EBITDA 17% 1% 13% 1% 37% 33% 19% Total: 5,404m 26% Total: 1,101m 4% 22% 3% 24% CHEMICALS WACKER SILICONES WACKER POLYMERS WACKER BIOSOLUTIONS Siltronic WACKER POLYSILICON Others/Consolidation 1 based on external sales 16 of 24

Full-Year Results 2016 FY and Q4 P&L in m % YoY Q4 2016 Q4 2015 % YoY Sales 5,404.2 5,296.2 2.0 1,357.6 1,232.9 10.1 EBITDA 1,101.4 1,048.8 5.0 271.6 188.4 44.2 EBITDA margin 20.4% 19.8% - 20.0% 15.3% - EBIT 366.2 473.4-22.6 81.2 33.7 >100 EBIT margin 6.8% 8.9% - 6.0% 2.7% - Result for the period 189.3 241.8-21.7 46.8 4.8 >100 EPS in 3.61 4.97-27.4 0.76 0.13 >100 17 of 24

Full-Year Results 2016 Sales Breakdown by Business, FY and Q4 Sales in m % YoY Q4 2016 Q4 2015 % YoY CHEMICALS 3,402.3 3,325.9 2.3 816.9 778.2 5.0 SILICONES 2,001.1 1,943.3 3.0 492.3 460.3 7.0 POLYMERS 1,194.8 1,185.5 0.8 275.0 273.3 0.6 BIOSOLUTIONS 206.4 197.1 4.7 49.6 44.6 11.2 POLYSILICON 1,095.5 1,063.6 3.0 297.2 241.5 23.1 Siltronic 933.4 931.3 0.2 246.3 215.3 14.4 Others 162.6 197.5-17.7 42.7 49.2-13.2 Consolidation -189.6-222.1-14.6-45.5-51.3-11.3 5,404.2 5,296.2 2.0 1,357.6 1,232.9 10.1 18 of 24

Full-Year Results 2016 EBITDA Breakdown by Business, FY and Q4 EBITDA in m %YoY Q4 2016 Q4 2015 %YoY CHEMICALS 659.2 530.6 24.2 131.2 97.1 35.1 SILICONES 361.2 276.2 30.8 78.9 49.6 59.1 POLYMERS 261.0 222.2 17.5 45.2 40.8 10.8 BIOSOLUTIONS 37.0 32.2 14.9 7.1 6.7 6.0 POLYSILICON 285.9 402.4-29.0 86.5 70.5 22.7 Siltronic 145.9 124.0 17.7 50.4 23.2 >100 Others 10.2-8.9 n.a. 3.8-4.0 n.a. Consolidation 0.2 0.7 n.a. -0.3 1.6 n.a. 1,101.4 1,048.8 5.0 271.6 188.4 44.2 19 of 24

Special EBITDA Effects 20m Special Income in 2016 Special income (in m) POLYSILICON: Retained prepayments & damages from cancelled contracts 2015 2016 Q1 Q2 Q3 Q4 FY Q1 Q2 Q3 Q4 FY 4.7 86.7 17.8 28.4 137.6-7.0-13.3 20.3 20 of 24

Siltronic Valuation Parameters per Consensus Siltronic FY2017e (as of February 28, 2017; 6 estimates) Analyst Consensus FY 2017e Average High Low Sales ( m) 1,046 1,068 1,014 EBITDA ( m) 228,3 253,4 205,6 Net income ( m) 82.7 93.5 65.6 Net cash per end of 2016: 175m Pension liabilities per end of 2016: 395m Wacker held 57.8% of Siltronic AG stock per 31. December 2016 21 of 24

Global PV Installations Further Broaden and Grow Country 2013 2014 2015 2016e 2017e France 0.6 0.9 0.9 0.6 1.0 1.2 Germany 3.3 1.9 1.5 1.5 1.5 1.7 Italy 1.1 0.6 0.3 0.4 0.4 0.5 Europe other 5.8 4.0 5.9 3.7 4.2 4.0 4.5 Europe total 10.8 7.4 8.6 6.2 6.7 6.9 7.9 Australia 0.9 1.0 0.9 0.8 1.0 1.0 1.2 China 12.9 13.2* 16.5* 30.5 24.0 27.0 India 1.0 1.0 2.1 4.2 4.4 8.5 9.5 Japan 6.8 9.3 10.8 8.0 8.5 7.5 8.0 USA 4.8 6.2 7.3 14.6 12.0 14.0 Rest of World 2.8 6.0 10.0 11.0 12.5 15.1 17.4 Total 40 GW 44 GW 56 GW ~75 78 GW ~75 85 GW Sources: SPE, IHS, Industry announcements, WACKER estimates; *China official data adjusted for installed/not connected capacity 22 of 24

Raw Material Prices With Volatile Development Prices Trend Upwards Si-Metal ( /MT) 2,750 2,500 2,250 2,000 1,750 2,620 Six-Year-High 0 2010 2011 2012 2013 2014 2015 2016 2017 Ethylene ( /MT) 1,400 1,300 1,200 1,100 1,000 900 1,345 Six-Year-High 1,591 Six-Year-Low 810 Six-Year-Low Source: CRU, Si-Metal Spot FD Europe 0 2010 2011 2012 2013 2014 2015 2016 2017 Source: ICIS, EN Contract FD NWE Methanol ( /MT) 445 Six-Year-High VAM ( /MT) 1,370 Six-Year-High 450 1,400 400 350 300 1,200 1,000 250 800 202 Six-Year-Low 0 2010 2011 2012 2013 2014 2015 2016 2017 Source: ICIS, MeOH Contract, FOB RDM 660 Six-Year-Low 0 2010 2011 2012 2013 2014 2015 2016 2017 Source: ICIS, VAM Contract FD NWE 23 of 24

WACKER: Issuer, Contact and Additional Information Issuer and Contact Additional Information Wacker Chemie AG Hanns-Seidel-Platz 4 D-81737 Munich Investor Relations contacts Joerg Hoffmann, CFA Tel. +49 89 6279 1633 joerg.hoffmann@wacker.com Scott McCollister Tel. +49 89 6279 1560 scott.mccollister@wacker.com Monika Stadler Tel. +49 89 6279 2769 monika.stadler.ir@wacker.com ISIN: WKN: Deutsche Börse: Ticker Bloomberg: Ticker Reuters: Listing: DE000WCH8881 WCH888 WCH CHM/WCH:GR CHE/WCHG.DE Frankfurt Stock Exchange Prime Standard Financial Calendar 04/27/17 Q1 Results 2017 05/19/17 Annual Shareholders' Meeting 07/28/17 Q2 Results 2017 10/04/17 Capital Market Day 10/26/17 Q3 Results 2017 24 of 24